Melodi Health Secures $10.75 Million in Series A Funding and Launches Pivotal ARIA Trial for Innovative Breast Reconstruction Device
Melodi Health, a trailblazer in breast reconstruction technology, has achieved two significant milestones: the successful close of a $10.75 million Series A funding round and the commencement of the pivotal “ARIA” investigational device exemption (IDE) trial. The company’s efforts are centered on its groundbreaking device, the Melodi Matrix™, aimed at addressing post-surgical complications in breast…